Searched for
SII POONAWALLA
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- ET Awards: DLF chairman emeritus Kushal Pal Singh calls for long-term urbanisation reforms to drive India’s growthKushal Pal Singh, DLF chairman emeritus, urges India to adopt a bold, long-term urbanisation strategy. He believes radical reforms are vita...
- ET Awards: Groww CEO Lalit Keshre on building India’s largest stock broking platform and future growth plansGroww, led by Lalit Keshre, has become India's top stock broking platform. The company recently saw its market capitalization surge signifi...
- ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwideCyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...
- Poonawalla's clear shot at access for all via route socialCyrus S Poonawalla, chairman of Serum Institute of India, has created a legacy where business and social impact go hand in hand. His vaccin...
- Funding for innovations key for India to remain vaccine leader: Cyrus PoonawallaSpeaking to ET after receiving the Lifetime Achievement Award for 2025 as part of the ET Awards for Corporate Excellence, Cyrus Poonawalla,...
- Cyrus Poonawalla suffers cardiac arrest, stable after angioplastyPoonawalla, 82, suffered cardiac arrest on Thursday. Dr Purvez Grant, a cardiologist from Ruby Hall Clinic said, "Cyrus Poonawalla suffered...
- SII's Poonawalla makes clarion call for global certification of vaccines"Multilateral organisations such as the United Nations and the World Trade Organisation should take it upon themselves to harmonise the cer...
- SII is working on an Omicron-specific vaccine, may launch it by the end of this year: ReportSII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further...
- Vaccine giant Serum Institute of India plans African plant in global expansionSII Chief Executive Adar Poonawalla said he was meeting some African officials in Davos to discuss his plans. Asked about possible investme...
- ET Business Leader of the Year 2021: Adar Poonawalla-A calculated bet that put India on the leaderboard of Covid fightbackWhen India was struck by the Covid-19 pandemic in March 2020, Poonawalla lost little time in stitching up an alliance with the Oxford Unive...
- WHO nod boosts Covovax chances of getting approval in IndiaCovovax is being manufactured in India by the Serum Institute of India (SII).
- Biocon unit plans 15% stake sale to Serum Institute for access to vaccinesThe deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the...
- Vaccine export ban 'very bad' move; son warned not to speak against it: SII's Cyrus Poonawala"It is a very bad move by the Modi government. My son asked me not to open my mouth. But it is my view that exports ought to be opened," Po...
- Serum Institute confident of European drug regulator nod for Covishield in a monthPoonawalla said SII has applied to the European Medicines Agency (EMA) through AstraZeneca. "The process has to take its time. An approval ...
- SII doing best to ramp up COVID-19 vaccine production, says CEO Adar PoonawallaBoth SII and Bharat Biotech are at the forefront of supplying COVID-19 vaccines in the country even as the second wave of the pandemic cont...
- Covishield dispatch for vaccine drive a historic moment: SIISerum Institute of India CEO Adar Poonawalla said the real challenge lies in taking the vaccine to the "common man, to the vulnerable group...
- Centre may purchase 300-400 million Covishield doses by July 2021: Adar PoonawallaSII has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine candidate 'Covidshield'. "As of now we don't h...
- Serum Institute founder Cyrus Poonawalla to keep some vaccine aside for ParsisThe newsletter, Parsi Junction, reported that Poonawalla acceded to the request of former Bombay Parsi Panchayat (BBP) chairman Dinshaw Rus...
Load More
